NCT02421471 - PMS to Evaluate the Safety and Efficacy of Picato® Gel | Biotech Hunter

Enrollment

1,324

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 19, 2018

Study Completion Date

January 19, 2018

Conditions

Actinic Keratosis

Interventions

DRUG

Ingenol mebutate 0.015 percent or 0.05 percent gel

Topical treatment with ingenol mebutate gel 0.015 percent or 0.05 percent gel of skin areas affected by AK

Trial Locations (1)

Department of Dermatology, Korea University Anam Hospital, Seoul